Age, Renal Dysfunction, Cardiovascular Disease, and Antihyperglycemic Treatment in Type 2 Diabetes Mellitus: Findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus

(2013) Christianne L. Roumie et al.   ANNALS OF INTERNAL MEDICINE

Comparative effectiveness of incident oral antidiabetic drugs on kidney function

(2012) Adriana M. Hung et al.   KIDNEY INTERNATIONAL

Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register

(2012) Nils Ekström et al.   BMJ Open

Intervention to Decrease Glyburide Use in Elderly Patients With Renal Insufficiency

(2011) Sherrie L. Aspinall et al.   American Journal Geriatric Pharmacotherapy

Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure

(2011) Meimei Yin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Association Between Glycemic Control and Adverse Outcomes in People With Diabetes Mellitus and Chronic Kidney Disease

(2011) Sabin Shurraw   ARCHIVES OF INTERNAL MEDICINE

Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice

(2011) Masanori Abe et al.   CURRENT DRUG METABOLISM

Diverging Association of Reduced Glomerular Filtration Rate and Albuminuria With Coronary and Noncoronary Events in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study

(2011) A. Solini et al.   DIABETES CARE

Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD study

(2011) David Sullivan et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

(2011) Tina Ken Schramm et al.   EUROPEAN HEART JOURNAL

Clinical significance of nonalbuminuric renal impairment in type 2 diabetes

(2011) Giuseppe Penno et al.   JOURNAL OF HYPERTENSION

Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) study

(2011) Giuseppe Pugliese et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?

(2011) Helen J. Nye et al.   NEPHRON CLINICAL PRACTICE

Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Metformin Use and Mortality Among Patients With Diabetes and AtherothrombosisMetformin Use With Diabetes and Atherothrombosis

(2010) Ronan Roussel   ARCHIVES OF INTERNAL MEDICINE

Anti-Infectives and the Risk of Severe Hypoglycemia in Users of Glipizide or Glyburide

(2010) H Schelleman et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Kidney function and risk triage in adults: threshold values and hierarchical importance

(2010) Robert N. Foley et al.   KIDNEY INTERNATIONAL

Frequency of Hypoglycemia and Its Significance in Chronic Kidney Disease

(2009) M. F. Moen et al.   Clinical Journal of the American Society of Nephrology

Dissociation of Aortic Pulse Wave Velocity With Risk Factors for Cardiovascular Disease Other Than Hypertension

(2009) Marina Cecelja et al.   HYPERTENSION

Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor

(2009) Marta Paiva et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE